Carboplatin
Title: Carboplatin
CAS Registry Number: 41575-94-4
CAS Name: (SP-4-2)-Diammine[1,1-cyclobutanedi(carboxylato-kO)(2-)]platinum
Additional Names: 1,1-cyclobutanedicarboxylic acid platinum complex; cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II); CBDCA
Manufacturers' Codes: JM-8; NSC-241240
Trademarks: Paraplatin (BMS)
Molecular Formula: C6H12N2O4Pt
Molecular Weight: 371.25
Percent Composition: C 19.41%, H 3.26%, N 7.55%, O 17.24%, Pt 52.55%
Literature References: Analog of cisplatin, q.v., with reduced nephrotoxicity. Prepn and antitumor activity: NL 7307863; M. J. Cleare et al., US 4140707 (1973, 1979 both to Research Corp.). Improved prepn: R. C. Harrison et al., Inorg. Chim. Acta 46, L15 (1980). Crystal structure: S. Neidle et al., J. Inorg. Biochem. 13, 205 (1980). Comparison with other antitumor platinum complexes: M. J. Cleare et al., Biochimie 60, 835 (1978). Early clinical studies: A. H. Calvert et al., Cancer Chemother. Pharmacol. 9, 140 (1982). Clinical pharmacokinetics: S. J. Harland et al., Cancer Res. 44, 1693 (1984); M. J. Egorin et al., ibid. 5432. Toxicity, activity in mice, rats, dogs: P. Lelieveld et al., Eur. J. Cancer Clin. Oncol. 20, 1087 (1984). Comparison with cisplatin chemotherapy in advanced seminoma: M. J. Peckham et al., Br. J. Cancer 52, 7 (1985). In treatment of small cell lung cancer: I. E. Smith et al., Cancer Treat. Rep. 69, 43 (1985).
Properties: White crystals, sol in water. LD50 in mice (mg/kg): 150 i.p., 140 i.v.; in rats (mg/kg): 85 i.v. (Lelieveld).
Toxicity data: LD50 in mice (mg/kg): 150 i.p., 140 i.v.; in rats (mg/kg): 85 i.v. (Lelieveld)
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic; Platinum Complexes.

Others monographs:
TEMPOLBecanthoneHepaxanthinFenoverine
NifedipinePyridinol CarbamateIsobenzanPotassium Hexacyanocobaltate(III)
ButofilololHexafluorenium BromideIsoniazidTrimellitic Anhydride
CloxyquinBromethalinTocamphylFisetin
©2016 DrugLead US FDA&EMEA